Target intelligence / Profile preview

RNA, U1 small nuclear 61, pseudogene (RNU1-61P)

Target
RNU1-61P
Molecular classification
Other, small nuclear RNA (snRNA) pseudogene
01

Overview

RNU1-61P, also known as "RNA, U1 small nuclear 61, pseudogene," is a non-coding RNA classified as a pseudogene related to U1 small nuclear RNA (snRNA). U1 snRNAs are essential components of the spliceosome complex, responsible for recognition of 5′ splice sites during pre-mRNA splicing and safeguarding nascent transcripts from premature polyadenylation. However, as a **pseudogene**, RNU1-61P is generally considered non-functional: it does not produce a mature, active RNA molecule and is not assembled into functional spliceosomal units. Many U1 snRNA pseudogenes and variant loci exist throughout the genome and can sometimes be transcribed, but they typically lack the necessary sequence elements for full biogenesis or interaction with spliceosomal proteins[2]. There is no evidence that RNU1-61P serves as a therapeutic, diagnostic, or pharmacological target, nor are there known drugs or safety concerns associated with it[4].

Other names
RNU1-61PU1 snRNA pseudogene 61
02

Biological functions

OtherAs a pseudogene, it does not have a canonical biological function; by analogy, functional U1 snRNA is involved in pre-mRNA splicing, but pseudogenes generally do not fulfill these roles.
03

Disease associations

OtherNo direct disease associations; pseudogenes are not generally implicated as direct disease factors, though changes in pseudogene expression can sometimes be markers or have regulatory effects in rare contexts.

Beyond the preview

Go deeper on RNA, U1 small nuclear 61, pseudogene (RNU1-61P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U1 small nuclear 61, pseudogene (RNU1-61P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call